Rupture of totally implantable central venous access devices (Intraports) in patients with cancer: report of four cases
- PDF / 744,551 Bytes
- 5 Pages / 610 x 792 pts Page_size
- 23 Downloads / 175 Views
Open Access
Case report
Rupture of totally implantable central venous access devices (Intraports) in patients with cancer: report of four cases Dimitrios K Filippou*1,2, Christoforos Tsikkinis1,3, Georgios K Filippou2, Athanasios Nissiotis1,3 and Spiros Rizos1,2 Address: 1Dept. of Surgical Oncology, Agii Anargiri Kifissias Anticancer Hospital, Greece, 21st Surgical Department, GPHP "Tzanion" Hospital, Piraeus, Athens, Greece and 33rd Surgical Department, Piraeus Anticancer Hospital "Metaxa", Piraeus, Greece Email: Dimitrios K Filippou* - [email protected]; Christoforos Tsikkinis - [email protected]; Georgios K Filippou - [email protected]; Athanasios Nissiotis - [email protected]; Spiros Rizos - [email protected] * Corresponding author
Published: 19 October 2004 World Journal of Surgical Oncology 2004, 2:36
doi:10.1186/1477-7819-2-36
Received: 01 July 2004 Accepted: 19 October 2004
This article is available from: http://www.wjso.com/content/2/1/36 © 2004 Filippou et al; licensee BioMed Central Ltd. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract Background: Totally implantable central venous access devices (intraports) are commonly used in cancer patients to administer chemotherapy or parenteral nutrition. Rupture of intraport is a rare complication. Patients and methods: During 3 years period, a total of 245 intraports were placed in cancer patients for chemotherapy. Four of these cases (two colon cancer and one each of pancreas and breast cancer) had rupture of the intraport catheter, these forms the basis of present report. Results: Mean time insitu for intraports was 164∀35 days. Median follow-up time was 290 days and total port time in situ was 40180 days. The incidence of port rupture was 1 per 10,000 port days. Three of the 4 cases were managed by successful removal of catheters. In two of these the catheter was removed under fluoroscopic control using femoral route, while in the third patient the catheter (partial rupture) was removed surgically. One of the catheters could not be removed and migrated to right ventricle on manipulations. Conclusion: Port catheter rupture is a rare but dreaded complication associated with subcutaneous port catheter device placement for chemotherapy. In case of such an event the patient should be managed by an experienced vascular surgeon and interventional radiologist, as in most cases the ruptured catheter can be retrieved by non operative interventional measures.
Background Totally implantable central venous access devices (intraports) are commonly used in patients with cancer to administer chemotherapy, blood and blood products, antibiotics, parenteral nutrition and to obtain blood samples for laboratory analysis. The catheter is usually placed in the subclavian vein under local anesthesia. There are
many compli
Data Loading...
